DMAC - DiaMedica Therapeutics Inc.
IEX Last Trade
5.34
-0.045 -0.843%
Share volume: 916
Last Updated: Fri 27 Dec 2024 02:30:19 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.33%
PREVIOUS CLOSE
CHG
CHG%
$5.38
-0.05
-0.84%
Summary score
22%
Profitability
25%
Dept financing
5%
Liquidity
50%
Performance
16%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Sep-2016 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-1609.25%
Return on assets
-38.73%
Return on sales
-319.72%
Return on invested capital
234.3%
Total debt ratio
41.66%
Debt ratio change over timeo
-0.61%
Current Ratio
7.66%
Quick Ratio
0%
Cash Position Ratio
3.1%
Short-term ratios 30-Sep-2019 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-20.86%
Return on assets
-19.87%
Return on sales
0%
Return on invested capital
260.97%
Total debt ratio
9.59%
Debt ratio change over timeo
-0.96%
Current Ratio
13.4%
Quick Ratio
0%
Cash Position Ratio
4.33%
Last quarter ratios 30-Sep-2020
The data are presented for the financials results of the last quarter.
Return on equity
-10.73%
Return on assets
-10.61%
Return on sales
0%
Return on invested capital
249.65%
Total debt ratio
4.84%
Debt ratio change over time
-0.98%
Current Ratio
21.56%
Quick Ratio
0%
Cash Position Ratio
6.79%
Performance ratios (change over 4 years) 30-Sep-2016 - 30-Sep-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-2899.94%
Return on assets
-134.78%
Return on sales
-181.56%
Return on invested capital
31.82%
Total debt ratio
-60.78%
Debt ratio change over time
-0.61%
Current Ratio
2.4%
Quick Ratio
0%
Cash Position Ratio
0.5%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | DMAC | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -1609.25% | -3.65% | 12.3% | 6.42% |
| Return on assets | -38.73% | 3.5% | 3.6% | 5.35% |
| Return on sales | -319.72% | 31.31% | 41.82% | 33.97% |
| Return on invested capital | 234.3% | 4.99% | 7.81% | 13.62% |
| Profitability | 25% | 36% | 68% | 60% |
| Total debt ratio | 41.66% | 101.15% | 75.51% | 29.75% |
| Debt ratio change over time | -0.61% | 224.03% | 6.03% | 1.46% |
| Dept financing | 10% | 50% | 19% | 8% |
| Current Ratio | 13.4% | 2.03% | 1.87% | 3.47% |
| Quick Ratio | 0% | 1.9% | 1.53% | 2.82% |
| Cash Position Ratio | 4.33% | 1.41% | 0.73% | 1.41% |
| Liquididy | 50% | 21% | 41% | 46% |
| Short-term ratios | DMAC | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -20.86% | -16.17% | 18.05% | 7.63% |
| Return on assets | -19.87% | 2.71% | 3.58% | 5.03% |
| Return on sales | 0% | 29.9% | 36.22% | 35.56% |
| Return on invested capital | 260.97% | 6.54% | 5.97% | 19.39% |
| Profitability | 25% | 35% | 68% | 62% |
| Total debt ratio | 9.59% | 99.31% | 83.77% | 30.59% |
| Debt ratio change over time | -0.96% | 851.68% | 10.97% | 0.58% |
| Dept financing | 2% | 50% | 21% | 8% |
| Current Ratio | 13.4% | 2.03% | 1.87% | 3.47% |
| Quick Ratio | 0% | 1.9% | 1.53% | 2.82% |
| Cash Position Ratio | 4.33% | 1.41% | 0.73% | 1.41% |
| Liquididy | 50% | 29% | 21% | 40% |